Innovent Biologics (suzhou) Co. Ltd.

This study aims to gather real-world information on how well the drug taletrectinib works and how safe it is for people with advanced ROS1-positive non-small cell lung cancer. It focuses on patients whose cancer has continued to grow despite treatment with another targeted drug c…

This study is testing a new injectable drug called IBI306 to see if it safely lowers 'bad' LDL cholesterol in adults with high cholesterol and mixed lipid levels. About 198 participants will be randomly assigned to receive either the real drug or a placebo (dummy) injection for 1…

This study is testing whether adding an experimental drug called IBI343 to other treatments is safe and effective for people with advanced stomach or pancreatic cancer that has a specific marker called CLDN18.2. About 389 participants will receive the combination therapy to see i…

This study is testing a new long-acting injectable medication called IBI3016 for people with mild to moderate high blood pressure. About 352 participants will receive either the drug or a placebo as an injection under the skin every 3 or 6 months for up to 2 years. The main goal …

This study is testing whether adding a new drug called IBI343 to a standard treatment helps people with advanced stomach or gastroesophageal cancer. The goal is to shrink the tumor before surgery and prevent it from coming back afterward. It is for patients whose tumors have a sp…

This study aims to see if a new drug called teprotumumab N01 works better than standard steroid treatment for controlling active Thyroid Eye Disease. About 92 adults with moderate-to-severe, recently active disease will be randomly assigned to receive either the new drug or the s…

This study is testing a drug called IBI363 given to patients before they have surgery to remove stage II or III non-small cell lung cancer. The goal is to see if the drug safely shrinks the tumor, making surgery more effective and potentially preventing the cancer from coming bac…

This is a very early study to check the safety of a new drug called IBI3033 and see how it moves through the body. It will involve 8 healthy volunteers who will receive the drug or a placebo. The main goal is to find out if the drug is safe and well-tolerated, not to treat any di…

This is a very early study to see if a new drug called IBI3033 is safe for people and how it moves through the body. It will involve 32 healthy adults who will receive either the drug or a placebo (a dummy treatment). The main goal is to check for any side effects and measure the…